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The response by a Joint Working Group of the Royal College of
Obstetricians and Gynaecologists and the British Society of
Gynaecological Cancer (1997) to the Report of the Expert
Advisory Group to the Chief Medical Officers of England and
Wales ‘A Policy Framework for Commissioning Cancer Services’
(1995) recommends that women with gynaecological malignancy
should be managed by multidisciplinary teams with a minimum
acceptable workload. However, while surveys have demonstrated
a positive association between throughput and outcome for breast
cancer and teratomas (Harding et al, 1993; Sainsbury et al, 1995),
this association has not yet been shown for gynaecological malig-
nancies. A recent survey of the management of women with
ovarian cancer failed to demonstrate any impact on survival of
operator throughput, although it did show a survival advantage for
women referred to an oncologist (Woodman et al, 1997). We
examine the influence of diagnostic throughput on survival in a
population-based series of women with cancer of the cervix.
MATERIALS AND METHODS
All women resident in Lancashire and Greater Manchester
diagnosed with invasive cancer of the cervix (International
Classification of Disease 9th revision, code 180) between
1 January 1990 and 31 December 1990 were identified from the
database held by the North Western Regional Cancer Registry
(NWRCR).
A case note review of these women was undertaken and details
on the following variables abstracted from the hospital records:
symptoms at presentation; stage; tumour type and grade; consul-
tant specialty; treatment modalities and referral to a clinical
oncologist. Stage at time of diagnosis was assessed by one
researcher (FC) using FIGO classification (1987).
Survival time was measured from date of first treatment or, if
not treated, date first seen, until date of death from any cause and
was censored after 31 December 1995. Vital status was ascertained
from records held by the NWRCR. Univariate survival estimates
were calculated using the Kaplan–Meier method and compared
using log-rank tests of significance (Kaplan and Meier, 1958).
Multivariate analyses were undertaken using Cox’s proportional
hazards model to investigate, simultaneously, the influence on
survival of patient- and disease-related factors (Cox, 1972).
Clinicians responsible for the diagnosis of the women in this
series were categorized as either gynaecologists or non-gynaecolo-
gists, but investigation of the association between diagnostic
throughput and outcome was restricted to gynaecologists. The
distribution of throughput values was divided into two or more
categories of contiguous values in as many ways as possible,
producing an exhaustive set of variables. Those variables for
which any category contained fewer than 10% of the study popula-
tion were excluded. The remaining throughput variables were then
examined in univariate and multivariate analyses.
RESULTS
A total of 381 eligible women were diagnosed with cancer of the
cervix during the study period. Excluded from further analysis
were seven women who were registered solely from death certifi-
cates, and 15 women for whom case notes were not available.
The characteristics of the remaining 359 (94%) women are
shown in Table 1. The mean age of these women was 53 years.
Stage was assigned by the author (FC) for 349 (97%) women,
although it was only explicitly documented in the case notes of
183 (51%) women. The stage assigned by the author corresponded
with that recorded by the clinician in 171 (93%) cases.
Univariate analyses identified age, stage, histology, presenting
symptom, place of diagnosis and referral to clinical oncologist
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as statistically significant prognostic variables (Table 1). In a
multivariate analysis, age, stage, histology and presenting
symptom remained statistically significant independent prognostic
variables (Table 2). Adverse prognostic factors were late stage at
presentation, uncommon histology and presentation with non-
gynaecological symptoms. Women referred to a clinical oncologist
had better outcome than those not referred but the observed differ-
ence was not statistically significant (c2 = 3.40, df = 1, P = 0.07)
(Table 2).
Women in this series were referred to 33 provider units; 23 (6%)
women were initially referred to non-gynaecologists, of whom 12
were subsequently transferred to the care of a gynaecologist. Of
the 348 woman assessed by a consultant gynaecologist, 97 (28%)
were assessed by gynaecologists diagnosing five or fewer cases in
1990, 153 (44%) by gynaecologists diagnosing between six
and ten cases and 97 (28%) by gynaecologists diagnosing more
than ten cases; the identity of the gynaecologist could not be
determined for one woman. No consistent evidence of an associa-
tion between the diagnostic throughput of the gynaecologist and
survival outcome was found either in the univariate or multivariate
analyses; this was true regardless of how the diagnostic workload
variable was defined. Relative risks of death (hazards ratios) for a
selection of workload variables are presented in Table 3.
Of the 182 (52%) women with stage IB/IIA cancer of the cervix,
97 (53%) were treated primarily with radiotherapy; 66 (36%) by
radical hysterectomy and two women refused treatment. For the
remaining 17 (9%) women, cancer had been an unexpected finding
at the time of a total abdominal hysterectomy which had been
undertaken for other reasons: ten women had had a preoperative
diagnosis of cervical intraepithelial neoplasia made at colposcopy;
three women had undergone hysterectomy for dysfunctional
uterine bleeding without a preceding cervical smear and the
remaining four women had presented with an abnormal smear
but had not undergone preoperative colposcopy. This failure to
Table 1 Distribution of population characteristics and univariate survival analysis of 359 women with cancer of the cervix
Survival %
n % 1-year 3-year 5-year
All cases 359 100.0 82.73 67.41 61.00
Age
[c2
(4) = 57.85, P < 0.001]a
0–39 87 24.2 95.40 86.21 85.06
40–49 80 22.3 90.00 80.00 71.25
50–59 64 17.8 85.94 60.94 54.69
60–69 66 18.4 71.21 56.06 46.97
70+ 62 17.3 64.52 43.55 35.48
Differentiation
[c2
(3) = 2.21, P = 0.53]a
Well 40 11.1 85.00 75.00 67.50
Moderate 86 24.0 77.91 63.95 56.98
Poor 111 30.9 84.68 66.67 59.46
Unknown 122 34.0 83.61 68.03 63.11
Stage
[c2
(4) = 230.81, P < 0.001]a
I 207 57.7 96.62 87.44 83.09
II 79 22.0 79.75 53.16 37.97
III 46 12.8 52.17 28.26 26.09
IV 17 4.7 23.53 5.88 0.00
Unknown 10 2.8 60.00 50.00 50.00
Histology
[c2
(2) = 13.64, P < 0.01]a
Squamous+adenosquamous 300 83.6 85.33 69.33 62.67
Adenocarcinoma 36 10.0 80.56 69.44 63.89
Others 23 6.4 52.17 39.13 34.78
Symptom
[c2
(2) = 133.53, P < 0.001]a
PV bleed 199 55.4 81.91 62.31 52.26
Abnormal smear 122 34.0 98.36 90.98 89.34
Others 38 10.6 36.84 18.42 15.79
Place of diagnosis
[c2
(2) = 69.88, P < 0.001]a
Outpatient 238 66.3 79.83 62.18 54.20
Colposcopy 102 28.4 97.06 89.22 85.29
Inpatient 19 5.3 42.11 15.79 15.79
Referral to oncologist
[c2
(1) = 16.81, P < 0.001]a
Not referred 115 32.0 82.61 79.13 78.26
Referred 244 68.0 82.79 61.89 52.87
aLog-rank test for heterogeneity.1960 F Clarke et al
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adequately assess women prior to surgery could not be related to
diagnostic throughput: four (24%) women were assessed by
gynaecologists with a diagnostic throughput of five or fewer cases;
six (35%) by gynaecologists with a diagnostic throughput of
between six and ten cases; and seven (41%) by gynaecologists
diagnosing more than ten cases (c2 = 1.89, df = 2, P = 0.39).
DISCUSSION
This analysis failed to demonstrate an association between diag-
nostic throughput and survival. The low rate of operative interven-
tion in this series of women precluded any further examination of
the impact of operator throughput on survival.
In order to demonstrate an association between throughput and
survival it is first necessary to reveal heterogeneity in the uptake of
an intervention of proven efficacy and then to further demonstrate
an association between heterogeneity of uptake of this intervention
and institutional or clinical throughput (Sainsbury et al, 1995).
When the uptake of effective interventions is dependent on
the adequacy of the initial assessment and this varies between
clinicians, then it would seem reasonable to further investigate the
possibility of a relationship between diagnostic throughput and
survival.
Audits of the management of women with cervical cancer have
demonstrated variation between institutions in the frequency with
which certain investigations are undertaken (Wolfe et al, 1996;
Jackson et al, 1997). Our survey also revealed suboptimal diag-
nostic practice. Only two-thirds of pathology reports contained a
comment on tumour grade but neither univariate nor multivariate
analysis confirmed tumour grade as an important prognostic
variable. In addition, 17 women received inadequate surgery
following a failure to exclude the presence of cancer of the cervix
at initial assessment. However, further analysis failed to demon-
strate an association between inadequate initial assessment and
diagnostic throughput.
Arguably, the benefits that might accrue from the centralization
of gynaecological cancer services are not solely measurable in
terms of survival outcome. Multidisciplinary specialist care might
also be expected to reduce morbidity and increase patient satisfac-
tion. However, little work has been undertaken to validate other
measures of the quality of gynaecological cancer services.
The Joint Working Party recommends that women with gynae-
cological malignancy are managed in fewer units (Joint Working
Group, 1997). Multidisciplinary teams in gynaecological oncology
centres would manage women who require radiotherapy,
chemotherapy or specialist surgery, and multidisciplinary teams in
associate units would manage women requiring less specialized
surgery. Apart from central pathological review, there are no
specific recommendations on who might best initially assess
women with symptoms suggestive of gynaecological cancer, but
Table 2 Determinants of outcome: multivariate survival comparison
Number of Relative risk 95% Confidence
deaths prior (ratio of hazards) interval
to 1 January 1996
Age
0–39 13 1.00 – Baseline –
40–49 24 1.59 0.79 to 3.18
50–59 29 2.85 1.44 to 5.61
60–69 35 2.43 1.23 to 4.79
70+ 42 2.70 1.39 to 5.22
c2
(4) = 12.92, P < 0.05a
Stage
I and not known 42 1.00 – Baseline –
II 50 3.67 2.28 to 5.90
III + IV 51 5.21 3.17 to 8.58
c2
(2) = 45.31, P < 0.0001a
Degree of differentiation
Well 13 1.00 – Baseline –
Moderate 39 1.02 0.54 to 1.94
Poor 46 1.24 0.66 to 2.34
Not known 45 0.80 0.42 to 1.55
c2
(3) = 3.68, P = 0.30a
Histological type
Squamous & adenosquamous 115 1.00 – Baseline –
Adenocarcinoma 13 1.24 0.69 to 2.24
Others 15 2.84 1.52 to 5.29
c2
(2) = 11.06, P < 0.01a
Presenting symptom
PV bleed 98 1.00 – Baseline –
Abnormal smear 13 0.33 0.17 to 0.63
Others 32 3.66 2.33 to 5.77
c2
(2) = 51.02, P < 0.0001a
Oncologist
Not referred 25 1.00 – Baseline–
Referred 118 0.61 0.36 to 1.03
c2
(1) = 3.40, P = 0.07a
aWald test for heterogeneityTable 3 Relative hazard ratiosa for varying combinations of diagnostic throughput of individual gynaecologists. (Each row in the table
refers to a different diagnostic throughput variable. For any given row, the range of throughput to which the hazards ratio applies is
determined by projecting the vertical lines which separate the ratios to meet the distribution of throughput values at the top of the table.
The reference (baseline) group is shaded)
Number of patients seen by individual consultants
(Number of consultants)b
1 2 345 67891 0 1 1 1 4 1 5 1 7 1 8 P-valuec
(14) (10) (9) (4) (4) (10) (4) (1) (3) (3) (3) (1) (1) (1) (1)
1.00 0.97 1.07 0.9189
1.00 0.98 1.00 0.77 0.8514
1.00 1.03 0.99 0.9814
1.00 1.00 0.9857






aRelative hazard ratios for different combinations of throughput, derived from a proportional hazards model controlling for age, degree of
differentiation, stage, histology, presenting symptom and referral to clinical oncologist. bTwelve women were excluded from this analysis:
ten women were not diagnosed by a gynaecologist; the identity of the diagnosing gynaecologist was unknown for a further two women.
cNominal P-value only. Several hundred hypotheses regarding diagnostic throughput were tested on this data, so the true P-value would
need adjusting to account for multiple testing.
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many gynaecologists anticipate a shift in primary care referrals
from ‘non designated’ units to multidisciplinary teams in associate
units or gynaecological oncology centres. Cancer of the cervix
most frequently presents following an abnormal smear or vaginal
bleeding; any major shift in the referral of women with these
symptoms to cancer centres or associate units could compromise
the viability of general gynaecological services in ‘non desig-
nated’ units. If the benefits of centralization are measured solely
by survival, then the findings of this study do not support any
change to the current pattern of referral of women with symptoms
suggestive of cancer of the cervix to general gynaecologists.
Further work is required to determine if these conclusions can be
confirmed for other common gynaecological malignancies.
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